AU Patent

AU2014271269B2 — Intravenous formulations of neurokinin-1 antagonists

Assigned to Opko Health Inc · Expires 2016-11-03 · 10y expired

What this patent protects

Pharmaceutical compositions for intravenous administration comprising the compound of Formula I, or pharmaceutically acceptable salts, hydrates or prodrugs thereof are described herein. Methods of preparing the pharmaceutical compositions and methods for treating nausea and/or em…

USPTO Abstract

Pharmaceutical compositions for intravenous administration comprising the compound of Formula I, or pharmaceutically acceptable salts, hydrates or prodrugs thereof are described herein. Methods of preparing the pharmaceutical compositions and methods for treating nausea and/or emesis with the pharmaceutical compositions are also described herein. HN, \ / Formula I 6004083 1 (GHMatters) P89480.AU.1 JENNYP

Drugs covered by this patent

Patent Metadata

Patent number
AU2014271269B2
Jurisdiction
AU
Classification
—
Expires
2016-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Opko Health Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.